Model Number: | W020 |
---|---|
Brand Name: | Wild White Biotechonlogy |
Grade: | Cosmetic Grade,Food Grade,Medicine Grade |
Place of Origin: | China (Mainland) |
Packaging: | Bottle,Can,Drum,Glass Container,Mason Jar,Vacuum Packed,1kg/bag25kg/drum,inner with vacuum packing or as the customer's requi, |
Extraction Type: | Solvent Extraction |
Form: | Powder |
Type: | |
Appearance: | Yellow White crystalline powder |
Quick Details
Specifications
1.Production
name: Irinotecan HCL trihydrate
2.Cas no.: 136572-09-3
3.Purity: 99% min
4.MF: C33H38N4O6.HCl
Product Information |
|
Product Name |
Irinotecan HCl Trihydrate 99.5% |
Molecular Formula |
C33H38N4O6·HCL·3H2O(677) |
Cas No. |
136572-09-3 |
Quality standard |
complies with In-house Standard |
Analysis |
Standard |
Assay(w/w) |
98.0~102.0% |
Purity(HPLC) |
≥99.5% |
Physical Control |
|
Appearance |
Light yellow or yellow crystalline powder |
Solubility |
Slightly soluble in water, ethanol or chloroform, nearly indiscerptible in acetone. |
Identification(by IR and HPLC) |
Conforms |
Specific Optical Rotation |
+60°~+73° |
Water |
7.0%~9.0% |
Chemical Control |
|
Residue of solvents |
Complies with ICH requirement |
Residue on Ignition |
NMT0.2% |
Chloride Content |
5.0~6.0% |
PH |
3.0~5.0 |
Heavy Metal |
NMT20PPM |
Relative Impurities |
NMT0.5% |
Individual Impurities |
NMT0.1% |
|
|
|
1 Irinotecan Hydrochloride (CPT-11) is an intravenous antineoplastic agent. Irinotecan Hydrochloride is a potent anticancer drug with activity in a broad range of experimental tumor models. Irinotecan Hydrochloride is one of many water-soluble derivatives of camptothecin (CPT), a cytotoxic plant alkaloid isolated from the Chinese tree Camptotheca acuminate. Irinotecan Hydrochloride has activity in colorectal cancer similar to 5-fluorouracil and appears to be partially non-crossresistant.
2 This product is antineoplastic. It is the first medicine that is used for treating the metastatic colon rectum cancer; it also has very good effects to non- small-cell carcinoma of the lung and small-cell carcinoma of the lung.